Recent News

• 05.09.2025 - Genetic Toxicity Evaluation of Melatonin in the Bacterial Reverse Mutation Assay
• 04.03.2025 - Epilepsy and Depression
• 01.24.2025 - Key Insights into Pharmacokinetics: How Drugs “Know Where to Act” and Their Journey Through the Body
• 11.20.2024 - The Endocannabinoid System and the Immune System: Understanding their interplay in health and Disease
• 06.24.2024 - Raising the Voice: A Comment on Race and Ethnic Disparities in Alzheimer’s Disease Clinical Research
• 06.24.2024 - Raising the Voice: A Comment on Race and Ethnic Disparities in Alzheimer’s Disease Clinical Research

Recent Filings

• 02.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.12.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 09.27.2024 - 4 Statement of changes in beneficial ownership of securities
• 09.27.2024 - 8-K Current report
• 08.27.2024 - 8-K Current report
• 08.27.2024 - EX-99.1 EX-99.1
• 08.14.2024 - SC 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.12.2024 - 4 Statement of changes in beneficial ownership of securities
• 08.09.2024 - 144 Report of proposed sale of securities
• 08.07.2024 - UPLOAD SEC-generated letter